Their team of expert cosmetologists ensures that each treatment is carried out with high safety standards in mind, giving you peace of mind while you enhance your health
MOTS-c is a mitochondrial-derived peptide (MDP) with broad intracellular signaling effects
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
You can double check it with the handy calculator at the very top of this page
Strong evidence supports FDA-approved indications where applicable
Quality: USP Grade, sterile, and non-pyrogenic, ensuring safety for parenteral administration